Yuki Miyai

508 total citations
10 papers, 258 citations indexed

About

Yuki Miyai is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Yuki Miyai has authored 10 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Immunology and 3 papers in Surgery. Recurrent topics in Yuki Miyai's work include Cancer Cells and Metastasis (5 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Immune cells in cancer (3 papers). Yuki Miyai is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Immune cells in cancer (3 papers). Yuki Miyai collaborates with scholars based in Japan. Yuki Miyai's co-authors include Atsushi Enomoto, Masahide Takahashi, Nobutoshi Esaki, Hiroki Kobayashi, Naoya Asai, Tadashi Iida, Yasuyuki Mizutani, Akitoshi Hara, Shinji Mii and Yukihiro Shiraki and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Pathology and Cancer Science.

In The Last Decade

Yuki Miyai

10 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuki Miyai Japan 7 171 99 62 61 39 10 258
Jordina Loubat‐Casanovas Spain 6 147 0.9× 186 1.9× 34 0.5× 56 0.9× 28 0.7× 6 305
Simona Nuzzo Italy 7 214 1.3× 222 2.2× 65 1.0× 84 1.4× 46 1.2× 10 388
Marice Alcantara United States 9 111 0.6× 95 1.0× 56 0.9× 46 0.8× 44 1.1× 12 218
Michael M. Allevato United States 7 145 0.8× 178 1.8× 79 1.3× 61 1.0× 56 1.4× 15 336
Matteo Ligorio United States 5 167 1.0× 97 1.0× 142 2.3× 96 1.6× 26 0.7× 7 302
Mireia Vallespinós Spain 5 164 1.0× 155 1.6× 143 2.3× 68 1.1× 19 0.5× 8 324
Fabio Scirocchi Italy 10 193 1.1× 130 1.3× 155 2.5× 87 1.4× 83 2.1× 15 395
Angelica Pace Italy 8 77 0.5× 114 1.2× 90 1.5× 69 1.1× 30 0.8× 10 252
Jacob Smigiel United States 7 251 1.5× 196 2.0× 72 1.2× 109 1.8× 38 1.0× 8 373
Chih‐Ming Pan Taiwan 10 171 1.0× 139 1.4× 115 1.9× 68 1.1× 27 0.7× 16 316

Countries citing papers authored by Yuki Miyai

Since Specialization
Citations

This map shows the geographic impact of Yuki Miyai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Miyai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Miyai more than expected).

Fields of papers citing papers by Yuki Miyai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Miyai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Miyai. The network helps show where Yuki Miyai may publish in the future.

Co-authorship network of co-authors of Yuki Miyai

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Miyai. A scholar is included among the top collaborators of Yuki Miyai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Miyai. Yuki Miyai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ando, Ryota, Yukihiro Shiraki, Yuki Miyai, et al.. (2023). Meflin is a marker of pancreatic stellate cells involved in fibrosis and epithelial regeneration in the pancreas. The Journal of Pathology. 262(1). 61–75. 6 indexed citations
2.
Miyai, Yuki, Daisuke Sugiyama, Tetsunari Hase, et al.. (2022). Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade. Life Science Alliance. 5(6). e202101230–e202101230. 34 indexed citations
3.
Shiraki, Yukihiro, Yasuyuki Mizutani, Tadashi Iida, et al.. (2022). Matrix remodeling‐associated protein 8 is a marker of a subset of cancer‐associated fibroblasts in pancreatic cancer. Pathology International. 72(3). 161–175. 9 indexed citations
4.
Takano, Yuko, Yuki Miyai, Sachi Morita, et al.. (2021). Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancer. International Cancer Conference Journal. 11(1). 67–70. 3 indexed citations
5.
Takahashi, Masahide, Hiroki Kobayashi, Yasuyuki Mizutani, et al.. (2021). Roles of the Mesenchymal Stromal/Stem Cell Marker Meflin/Islr in Cancer Fibrosis. Frontiers in Cell and Developmental Biology. 9. 749924–749924. 30 indexed citations
6.
Hara, Akitoshi, Katsuhiro Kato, Toshikazu Ishihara, et al.. (2021). Meflin defines mesenchymal stem cells and/or their early progenitors with multilineage differentiation capacity. Genes to Cells. 26(7). 495–512. 16 indexed citations
7.
Ohara, Yuuki, Atsushi Enomoto, Kotaro Sato, et al.. (2020). Connective tissue growth factor produced by cancer‑associated fibroblasts correlates with poor prognosis in epithelioid malignant pleural mesothelioma. Oncology Reports. 44(3). 838–848. 23 indexed citations
8.
Maeda, Osamu, Tomoki Ebata, Tomoya Shimokata, et al.. (2020). Chemotherapy for biliary tract cancer: real-world experience in a single institute.. PubMed. 82(4). 725–733. 1 indexed citations
9.
Miyai, Yuki, Nobutoshi Esaki, Masahide Takahashi, & Atsushi Enomoto. (2020). Cancer‐associated fibroblasts that restrain cancer progression: Hypotheses and perspectives. Cancer Science. 111(4). 1047–1057. 134 indexed citations
10.
Miyai, Yuki, Atsushi Enomoto, Yuichi Ando, & Masahide Takahashi. (2020). Significance of meflin-positive cancer-associated fibroblasts in predicting response to immune checkpoint inhibitors in non-small cell lung cancer.. Journal of Clinical Oncology. 38(15_suppl). 3118–3118. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jordina Loubat‐Casanovas Breakdown of academic impact, for papers by Simona Nuzzo Breakdown of academic impact, for papers by Marice Alcantara Breakdown of academic impact, for papers by Michael M. Allevato Breakdown of academic impact, for papers by Matteo Ligorio Breakdown of academic impact, for papers by Mireia Vallespinós Breakdown of academic impact, for papers by Fabio Scirocchi Breakdown of academic impact, for papers by Angelica Pace Breakdown of academic impact, for papers by Jacob Smigiel Breakdown of academic impact, for papers by Chih‐Ming Pan
Rankless by CCL
2026